Nom du produit:tert-Butyl 6-bromospiro[indene-1,4'-piperidine]-1'-carboxylate
IUPAC Name:tert-butyl 6-bromospiro[indene-1,4'-piperidine]-1'-carboxylate
- CAS:158628-80-9
- Formule moléculaire:C18H22BrNO2
- Pureté:95%
- Numéro de catalogue:CM139224
- Poids moléculaire:364.28
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:158628-80-9
- Formule moléculaire:C18H22BrNO2
- Point de fusion:-
- Code SMILES:CC(C)(C)OC(=O)N1CCC2(CC1)C=CC1=CC=C(Br)C=C21
- Densité:
- Numéro de catalogue:CM139224
- Poids moléculaire:364.28
- Point d'ébullition:
- N° Mdl:MFCD12198625
- Stockage:Store at 2-8°C.
Category Infos
- Piperidines
- Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
- Piperidine,Piperidine Price
- if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
- Indenes
- Indenes are useful building blocks found in a variety of biologically relevant products.
Column Infos
- Spiro Compounds
- A spiro compound is a polycyclic compound in which two monocyclic rings share one carbon atom; the shared carbon atom is called a spiro atom. Spiro compounds have rigid structures, stable structures, and have special properties that general organic compounds do not possess, such as anomeric effect, spiro conjugation and spiro hyperconjugation. Compared with the monocyclic structure or the planar aromatic structure, the spiro structure has a larger three-dimensional structure; the heterocyclic spiro structure is also regarded as the biological isostere of some groups, which can change the drug to a certain extent. The water solubility, lipophilicity, dominant conformation and ADMET properties of the molecule make the optimized lead molecule easier to drug. Therefore, spiro compounds occupy a very important position in drug development.